The present invention relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.
本发明涉及融合吗啉
吡嘧啶类化合物,包括有效量的融合吗啉
吡嘧啶的药物组合物以及使用融合吗啉
吡嘧啶治疗神经退行性疾病的方法,包括向需要的受试者施用有效量的融合吗啉
吡嘧啶。